Multiple myeloma (MM) treatment has changed tremendously, with significant improvement in patient out-comes. One group with a suboptimal benefit is patients with high-risk cytogenetics, as tested by ...

Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...

CHATSWORTH, Calif., Nov. 29, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and a provider of high value personalized ...

Genetic testing is a minimally invasive medical test that doctors use to identify genetic mutations or variants that can lead to certain diseases or conditions. Doctors use various types of genetic ...

Cytogenetic tests evaluate whole chromosomes from the nucleus of the cell for changes in number or structure. Cytogenetic testing is often the first tier of genetic testing for a number of clinical ...

Genetic testing should be offered to myeloma patients to identify high-risk cases earlier and enable more targeted and effective treatment, according to experts. A study by The Institute of Cancer ...

Our previous study evaluated the frequency of microscopic and submicroscopic copy-number variations in patients presenting for prenatal diagnostic testing for a variety of indications. 5 To evaluate ...

SAN DIEGO, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that a team led by Dr. Alexander Hoischen from Radboud University Medical Center (RUMC) in the ...

The "Genetic Testing Market by Type, Technology, Application: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com’s offering. The genetic ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Molecular Cytogenetics Market - Forecast to 2021" report to their offering. The molecular cytogenetics market is ...